D. Spriggs

发表

Efficacy of live, attenuated, human rotavirus vaccine 89–12 in infants: a randomised placebo-controlled trial

D. Bernstein, D. Sack, E. Rothstein, 1999, The Lancet.

Genetic basis for altered pathogenesis of an immune-selected antigenic variant of reovirus type 3 (Dearing)

K. Tyler, D. Spriggs, R. Bassel-Duby, 1986, Journal of virology.

Identification of attenuating mutations on the reovirus type 3 S1 double-stranded RNA segment with a rapid sequencing technique

K. Tyler, D. Spriggs, R. Bassel-Duby, 1986, Journal of virology.

Public Health Considerations for the Use of Cholera Vaccines in Cholera Control Programs

D. Sack, D. Spriggs, J. Clemens, 1994 .

Terms of engulfment: transformation in Haemophilus influenzae.

D. Spriggs, 1987, The Journal of infectious diseases.

Specific plasma membrane receptors for reovirus on rat pituitary cells in culture.

C. Kahn, D. Spriggs, B. Fields, 1983, The Journal of clinical investigation.

Evidence for functional domains on the reovirus type 3 hemagglutinin.

D. Spriggs, B. Fields, S. Burstin, 1982, Virology.

From the National Institute of Allergy and Infectious Diseases. Summary of the 25th United States-Japan Joint Conference on cholera and related diarrheal diseases.

D. Spriggs, R. Sack, 1990, The Journal of infectious diseases.

Hemagglutinin variants of reovirus type 3 have altered central nervous system tropism.

R. Bronson, D. Spriggs, B. Fields, 1983, Science.

Host immune response to reovirus: CTL recognize the major neutralization domain of the viral hemagglutinin.

D. Spriggs, R. Finberg, B. Fields, 1982, Journal of immunology.

Role of Mycobactin in the Growth and Virulence of Tubercle Bacilli

D. Spriggs, I. Kochan, C. Golden, 1974, Infection and immunity.

Comparison of alternative buffers for use with a new live oral cholera vaccine, Peru-15, in outpatient volunteers

D. Sack, D. O'Sullivan, D. Spriggs, 1997, Infection and immunity.

Attenuated reovirus type 3 strains generated by selection of haemagglutinin antigenic variants

D. Spriggs, B. Fields, 1982, Nature.

Identification of idiotypic receptors on reovirus-specific cytolytic T cells.

D. Spriggs, J. Noseworthy, H. Ertl, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Identification of the major structural proteins of two BALB/c myeloma C-type viruses.

D. Spriggs, R. G. Krueger, 1979, Virology.

Topological analysis of the reovirus type 3 hemagglutinin.

D. Spriggs, B. Fields, K. Kaye, 1983, Virology.

Envelope proteins of the BALB/c myeloma mink cell focus-inducing (MCF) viruses.

D. Spriggs, R. G. Krueger, 1981, Virology.

BALB/c myeloma retroviruses have mink cell focus-inducing activity

D. Spriggs, R. G. Krueger, M. Diebold, 1980, Journal of virology.

Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cells

H. Weiner, M. Dichter, D. Spriggs, 1982, The Journal of experimental medicine.

IDENTIFICATION O F A HEMAGGLUTININ-SP ECIFIC IDIOTYPE A SSOCIATED W ITH R EOVIRUS R ECOGNITION SHARED BY LYMPHOID A ND N EURAL C ELLS*

H. Weiner, M. Dichter, D. Spriggs, 1982 .

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12.

D. Bernstein, V. Smith, D. Spriggs, 1998, Vaccine.

BALB/c myeloma retroviruses: peptide mapping and immunological analysis of the pp12 structural protein

D. Spriggs, R. G. Krueger, 1980, Journal of virology.

Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae 0139 vaccine prototype

M. Waldor, D. Spriggs, J. Mekalanos, 1995, The Lancet.

Evaluation of Peru-15, a new live oral vaccine for cholera, in volunteers.

D. Sack, D. O'Sullivan, D. Spriggs, 1997, The Journal of infectious diseases.

Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1.

D. Spriggs, J. Mekalanos, K. Killeen, 1995, The Journal of infectious diseases.

Efficacy of Live, Attenuated Human Rotavirus Vaccine (89-12) in Infants

D. Bernstein, D. Sack, E. Rothstein, 1999 .

Bacterial mucosal vaccines: Vibrio cholerae as a live attenuated vaccine/vector paradigm.

D. Spriggs, J. Mekalanos, K. Killeen, 1999, Current topics in microbiology and immunology.

Legionella, microbial ecology, and inconspicuous consumption.

D. Spriggs, 1987, The Journal of infectious diseases.